J.M. HUBER MICROPOWDERS, INC. – Trademark Portfolio
Entity Type: 03
J.M. HUBER MICROPOWDERS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NUGRAN and NUTRI GRANULATIONS. The owner is based in EDISON, NJ.
499 THORNALL STREET, 8TH FLOOR
EDISON, NJ 08837
Showing of trademarks Trademarks
Trademark Classifications
J.M. HUBER MICROPOWDERS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does J.M. HUBER MICROPOWDERS, INC. have?
J.M. HUBER MICROPOWDERS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does J.M. HUBER MICROPOWDERS, INC. file in?
J.M. HUBER MICROPOWDERS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 29 (Meats & Processed Foods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are J.M. HUBER MICROPOWDERS, INC.'s most well-known trademarks?
J.M. HUBER MICROPOWDERS, INC.'s registered trademark portfolio includes well-known marks such as NUGRAN and NUTRI GRANULATIONS. These are among 3 currently registered trademarks in the portfolio.
What is J.M. HUBER MICROPOWDERS, INC.'s trademark registration success rate?
J.M. HUBER MICROPOWDERS, INC. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.